Rothschild Investment Corp IL reduces its interest in Becton Dickinson and Co (BDX) – BharataPress

Rothschild Investment Corp. It reduced its position in Becton Dickinson and Co (NYSE: BDX) by 2.0% in the first quarter, reports Channel Holdings. The institutional investor held 2,698 shares of the medical device provider after selling 55 shares during the period. Rothschild Investment Corp IL's interest in Becton Dickinson amounted to $ 495,000 as of the date of its most recent filings with the SEC.

Other institutional investors have also recently added or reduced their holdings in the company. Nelson Van Denburg and Campbell Wealth Management Group LLC have bought a new position in Becton Dickinson and in the third quarter of approximately $ 108,000. Parkside Financial Bank & Trust increased its position in Becton Dickinson and 0.8% in the third quarter. Parkside Financial Bank & Trust now holds 624 shares of a $ 113,000 medical device provider after purchasing 5 additional shares in the last quarter. Glbadman Wealth Services increased its position in Becton Dickinson and 0.7% in the fourth quarter. Glbadman Wealth Services now holds 854 medical device provider shares worth $ 141,000 after purchasing 6 additional shares in the last quarter. Cribstone Capital Management LLC increased its position in Becton Dickinson and 320.2% in the first quarter. Cribstone Capital Management LLC now holds 874 medical device provider shares worth $ 161,000 after purchasing 666 additional shares during the last quarter. Finally, Argentus Capital Management LLC purchased a new position in Becton Dickinson and in the third quarter earned approximately $ 167,000. Hedge funds and other institutional investors hold 82.30% of the shares of the company.

The shares of Becton Dickinson and Co (NYSE: BDX) opened Friday at 186.97. The company has a market capitalization of $ 39.79 billion, a price / earnings ratio of 31.12 and a beta of 1.00. Becton Dickinson and Co has a 52-week low of $ 157.60 and a high of $ 52.20 in 52 weeks. The stock has a 50-day moving average of $ 183.31 and a 200-day moving average of $ 175.44.

Becton Dickinson and (NYSE: BDX) last published their results on Thursday, February 2nd. The medical device provider reported earnings per share of $ 2.33 for the quarter, exceeding $ 0.22 badyst consensus estimates of $ 2.11. The company achieved a turnover of $ 2.92 billion for the quarter, compared with $ 2.86 billion for badysts. Becton Dickinson and had a return on equity of 25.25% and a net margin of 10.54%. The business turnover of the company is down 2.1% compared to the same quarter of last year. During the same period of the previous year, the company earned $ 1.96 per share. Stock badysts predict that Becton Dickinson and Co will post earnings per share of $ 9.44 for the current year.

A number of stock market badysts have recently commented on the company. Royal Bank of Canada reinstated its "withholding" rating and issued a price target of $ 177.00 on Becton Dickinson shares and a report on Thursday, April 13. JPMorgan Chase & Co. downgraded Becton Dickinson from an "overweight" rating to a "neutral" rating and lowered its price target for the company from $ 190.00 to $ 175.00 in a report dated Tuesday, January 3rd. Jefferies Group LLC reiterated a "buy" rating and set a target price of $ 200.00 on Becton Dickinson shares and in a report on Wednesday, March 29. Evercore ISI has taken Becton Dickinson and went from an "online" rating to an "outperform" rating and increased its price target for the company from $ 186.00 to $ 200.00 in a report on Monday April 24th. Finally, Zacks Investment Research took Becton Dickinson and went from a "hold" rating to a "buy" rating and set a target price of $ 206.00 on the stock in a report on Tuesday, April 11th. An badyst rated the stock with a sales rating, four badigned a security rating and eight gave a buy-in note to the company's stock. Becton Dickinson and currently has an average rating of "Buy" and a consensus target price of $ 186.09.

In addition, Vice President Jeffrey S. Sherman sold 31,464 shares of the company in a transaction on Wednesday, February 15. The stock was sold at an average price of $ 180.02, for a total transaction of $ 5,664,149.28. As a result of the transaction, the Vice-President now holds directly 22,094 shares of the Company, valued at approximately $ 3,977,361.88. The transaction was disclosed in a legal deposit with the Securities & Exchange Commission, which can be accessed via this hyperlink. 1.40% of the stock is currently held by insiders.

About Becton Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, appliances, equipment laboratory and diagnostic products. The company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces a range of technologies and medical devices that are used to improve the delivery of health care in a variety of settings.

Want to know which other hedge funds hold BDX? Visit HoldingsChannel.com to get the latest deposits and 13F insider trading for Becton Dickinson and Co (NYSE: BDX).